Researchers are mainly exploring whether they can help reduce cravings, with early signals around alcohol being encouraging but preliminary
Pipeline report flags continued pressure The insurer's annual outlook, aimed at private plan sponsors, lists GLP-1 therapies among the leading themes of 2026 and warns that ongoing launches of newer, more expensive drugs are putting increased financial pressure on private drug plans
Hemoglobin A1c Reduction With the GLP-1 Receptor Agonist Semaglutide Is Independent of Baseline eGFR: post hoc Analysis of the SUSTAIN and PIONEER Programs
As mentioned above, Zepbound slows gastric emptying , the process of food moving from the stomach into the intestines
Patients and clinicians can take several evidence-based steps to minimize kidney risks while using weight loss injections
People who suffer from AGHD are also more likely to suffer from heart attacks, as HGH levels are not sufficient to maintain organ health